Pages

Tuesday, November 1, 2011

VentriPoint Commences Clinical Studies of Pulmonary Arterial Hypertension Application of Right Heart Analysis System

- The University of Chicago Completes First Patient - SEATTLE, WASHINGTON--(Marketwire - Nov. 1, 2011) - VentriPoint Diagnostics (TSX VENTURE:VPT)(PINK SHEETS:VPTDF) announces the University of Chicago has secured a VentriPoint Medical System (VMS™) and has begun the clinical evaluation of the database for patients with Pulmonary Arterial Hypertension (PAH). The study will be led by four highly regarded cardiac specialists from the University of Chicago; Dr. Roberto Lang, former President...continued
    

No comments:

Post a Comment